ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Adial Pharma Selects Crown CRO for Phase III Trial
November 28, 2018Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, has selected Crown CRO, based in Finland, to manage its Phase III trial for AD04 for the treatment of alcohol use disorder (AUD). -
Selumetinib Granted Orphan Designation in Europe
August 06, 2018AstraZeneca and Merck announced that the European Medicines Agency (EMA) has granted orphan designation to selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1). -
Abeona Therapeutics receives FDA orphan designation for gene therapy
May 31, 2017The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Abeona Therapeutics’s EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa (DEB). -
Spark Therapeutics Earns $15M Pfizer Milestone
January 06, 2017Spark Therapeutics has earned a $15 million milestone payment from Pfizer for achieving a pre-specified safety and efficacy profile in the ongoing hemophilia B Phase 1/2 trial of SPK-9001.
Pharma Sources Insight January 2025
